Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Bitner, R. Scott Browman, Kaitlin E Brune, Michael E Fung, Steven Jacobson, Peer B Rueter, Lynne E Strakhova, Marina I Wang, Jiahong Rohde, Jeffrey J Shuai, Qi Link, James T Patel, Jyoti R Dinges, Jurgen Sorensen, Bryan K Yong, Hong Yeh, Vince S Kurukulasuriya, Ravi |
| description | The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08198331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08198331</sourcerecordid><originalsourceid>FETCH-uspatents_grants_081983313</originalsourceid><addsrcrecordid>eNrjZHDxzMvITMosyS8qVshPUyjJSFUwNNRNSi1J1M2oTCnKr6gsLkktys9MUUhJBQukp-YlFqcqlFQWAFUqpOZVVeam8jCwpiXmFKfyQmluBgU31xBnD93S4oLEktS8kuL49KJEEGVgYWhpYWxsaEyEEgBddzOC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme</title><source>USPTO Issued Patents</source><creator>Bitner, R. Scott ; Browman, Kaitlin E ; Brune, Michael E ; Fung, Steven ; Jacobson, Peer B ; Rueter, Lynne E ; Strakhova, Marina I ; Wang, Jiahong ; Rohde, Jeffrey J ; Shuai, Qi ; Link, James T ; Patel, Jyoti R ; Dinges, Jurgen ; Sorensen, Bryan K ; Yong, Hong ; Yeh, Vince S ; Kurukulasuriya, Ravi</creator><creatorcontrib>Bitner, R. Scott ; Browman, Kaitlin E ; Brune, Michael E ; Fung, Steven ; Jacobson, Peer B ; Rueter, Lynne E ; Strakhova, Marina I ; Wang, Jiahong ; Rohde, Jeffrey J ; Shuai, Qi ; Link, James T ; Patel, Jyoti R ; Dinges, Jurgen ; Sorensen, Bryan K ; Yong, Hong ; Yeh, Vince S ; Kurukulasuriya, Ravi ; Abbott Laboratories</creatorcontrib><description>The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8198331$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8198331$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bitner, R. Scott</creatorcontrib><creatorcontrib>Browman, Kaitlin E</creatorcontrib><creatorcontrib>Brune, Michael E</creatorcontrib><creatorcontrib>Fung, Steven</creatorcontrib><creatorcontrib>Jacobson, Peer B</creatorcontrib><creatorcontrib>Rueter, Lynne E</creatorcontrib><creatorcontrib>Strakhova, Marina I</creatorcontrib><creatorcontrib>Wang, Jiahong</creatorcontrib><creatorcontrib>Rohde, Jeffrey J</creatorcontrib><creatorcontrib>Shuai, Qi</creatorcontrib><creatorcontrib>Link, James T</creatorcontrib><creatorcontrib>Patel, Jyoti R</creatorcontrib><creatorcontrib>Dinges, Jurgen</creatorcontrib><creatorcontrib>Sorensen, Bryan K</creatorcontrib><creatorcontrib>Yong, Hong</creatorcontrib><creatorcontrib>Yeh, Vince S</creatorcontrib><creatorcontrib>Kurukulasuriya, Ravi</creatorcontrib><creatorcontrib>Abbott Laboratories</creatorcontrib><title>Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme</title><description>The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZHDxzMvITMosyS8qVshPUyjJSFUwNNRNSi1J1M2oTCnKr6gsLkktys9MUUhJBQukp-YlFqcqlFQWAFUqpOZVVeam8jCwpiXmFKfyQmluBgU31xBnD93S4oLEktS8kuL49KJEEGVgYWhpYWxsaEyEEgBddzOC</recordid><startdate>20120612</startdate><enddate>20120612</enddate><creator>Bitner, R. Scott</creator><creator>Browman, Kaitlin E</creator><creator>Brune, Michael E</creator><creator>Fung, Steven</creator><creator>Jacobson, Peer B</creator><creator>Rueter, Lynne E</creator><creator>Strakhova, Marina I</creator><creator>Wang, Jiahong</creator><creator>Rohde, Jeffrey J</creator><creator>Shuai, Qi</creator><creator>Link, James T</creator><creator>Patel, Jyoti R</creator><creator>Dinges, Jurgen</creator><creator>Sorensen, Bryan K</creator><creator>Yong, Hong</creator><creator>Yeh, Vince S</creator><creator>Kurukulasuriya, Ravi</creator><scope>EFH</scope></search><sort><creationdate>20120612</creationdate><title>Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme</title><author>Bitner, R. Scott ; Browman, Kaitlin E ; Brune, Michael E ; Fung, Steven ; Jacobson, Peer B ; Rueter, Lynne E ; Strakhova, Marina I ; Wang, Jiahong ; Rohde, Jeffrey J ; Shuai, Qi ; Link, James T ; Patel, Jyoti R ; Dinges, Jurgen ; Sorensen, Bryan K ; Yong, Hong ; Yeh, Vince S ; Kurukulasuriya, Ravi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_081983313</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bitner, R. Scott</creatorcontrib><creatorcontrib>Browman, Kaitlin E</creatorcontrib><creatorcontrib>Brune, Michael E</creatorcontrib><creatorcontrib>Fung, Steven</creatorcontrib><creatorcontrib>Jacobson, Peer B</creatorcontrib><creatorcontrib>Rueter, Lynne E</creatorcontrib><creatorcontrib>Strakhova, Marina I</creatorcontrib><creatorcontrib>Wang, Jiahong</creatorcontrib><creatorcontrib>Rohde, Jeffrey J</creatorcontrib><creatorcontrib>Shuai, Qi</creatorcontrib><creatorcontrib>Link, James T</creatorcontrib><creatorcontrib>Patel, Jyoti R</creatorcontrib><creatorcontrib>Dinges, Jurgen</creatorcontrib><creatorcontrib>Sorensen, Bryan K</creatorcontrib><creatorcontrib>Yong, Hong</creatorcontrib><creatorcontrib>Yeh, Vince S</creatorcontrib><creatorcontrib>Kurukulasuriya, Ravi</creatorcontrib><creatorcontrib>Abbott Laboratories</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bitner, R. Scott</au><au>Browman, Kaitlin E</au><au>Brune, Michael E</au><au>Fung, Steven</au><au>Jacobson, Peer B</au><au>Rueter, Lynne E</au><au>Strakhova, Marina I</au><au>Wang, Jiahong</au><au>Rohde, Jeffrey J</au><au>Shuai, Qi</au><au>Link, James T</au><au>Patel, Jyoti R</au><au>Dinges, Jurgen</au><au>Sorensen, Bryan K</au><au>Yong, Hong</au><au>Yeh, Vince S</au><au>Kurukulasuriya, Ravi</au><aucorp>Abbott Laboratories</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme</title><date>2012-06-12</date><risdate>2012</risdate><abstract>The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_08198331 |
| source | USPTO Issued Patents |
| title | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A30%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bitner,%20R.%20Scott&rft.aucorp=Abbott%20Laboratories&rft.date=2012-06-12&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08198331%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |